villous adenocarcinoma

Description

Villous Adenocarcinoma: A Rare and Diagnostically Challenging Subset of Colorectal Cancer

Villous adenocarcinoma is a rare and diagnostically challenging subset of colorectal adenocarcinoma. It accounts for approximately 3-5% of all colorectal carcinomas [1]. This type of cancer has villous or adenoma-like features, making it difficult to distinguish from benign polyps.

Characteristics

Villous adenocarcinoma is characterized by its invasive nature and architectural and cytologic features resembling villous adenoma. It may have a traditional invasive component or invade by pushing [1]. This type of cancer can occur in the colon and other parts of the gastrointestinal tract, as well as in other parts of the body.

Epidemiology

Villous adenocarcinoma is more common in older patients, with both genders affected. It typically occurs in the rectosigmoid or rectum and is often 3-4 cm in size [8].

Clinical Presentation

Patients with villous adenocarcinoma may present with hematuria and/or irritative symptoms, although this can vary depending on the location of the tumor.

Prognosis

Despite its rarity, villous adenocarcinoma has a favorable prognosis compared to other types of colorectal cancer. Classifying these tumors as a special type of colorectal cancer may facilitate the development of diagnostic adjuncts and optimal treatment protocols [4].

References:

[1] Context 1 [2] Context 3 [4] Context 4 [8] Context 8

Signs and Symptoms

Common Signs and Symptoms of Villous Adenocarcinoma

Villous adenocarcinoma, a type of cancer that affects the glands and glandular tissue in the large intestine, can exhibit various signs and symptoms. While some cases may be asymptomatic, others may present with the following common symptoms:

  • Flatulence: A feeling of gas or air in the digestive system, which can lead to bloating and discomfort [8].
  • Diarrhea: Frequent bowel movements, often accompanied by a change in stool consistency or color [5].
  • Painless bright red or dark red blood: When wiping oneself after a bowel movement, some individuals may notice blood in their stool [4].
  • Vague symptoms: In some cases, the signs and symptoms of villous adenocarcinoma can be non-specific, making it challenging to diagnose the condition early on [7].

Other Possible Symptoms

While not as common, other possible symptoms of villous adenocarcinoma may include:

  • Abdominal pain or discomfort: A feeling of tenderness or cramping in the abdominal area.
  • Weight loss: Unintentional weight loss due to changes in appetite or metabolism.

It's essential to note that not everyone with villous adenocarcinoma will experience symptoms. If you're experiencing any unusual changes in your body, it's crucial to consult a healthcare professional for proper evaluation and diagnosis.

References:

[4] - Symptoms of tubular adenomas [5] - Symptoms of villous adenoma [7] - Signs and symptoms are vague; bleeding per rectum may not occur. [8] - History and Symptoms​​ Villous adenoma is commonly asymptomatic but sometimes patients may present with the following symptoms: Flatulence.

Additional Symptoms

Diagnostic Tests

To provide information on diagnostic tests for villous adenocarcinoma, I'll rely on the context provided.

Diagnostic Tests

Villous adenocarcinoma is a type of cancer that affects the colon or rectum. The following diagnostic tests are commonly used to detect and confirm this condition:

  • Colonoscopy: A colonoscopy is a procedure where a flexible tube with a camera and light on the end (colonoscope) is inserted through the rectum to visualize the inside of the colon and rectum. This test can help identify polyps, tumors, or other abnormalities in the colon or rectum [1].
  • Biopsy: A biopsy involves taking a sample of tissue from the suspicious area using a special instrument called a biopsy forceps. The tissue is then examined under a microscope to confirm the presence of cancer cells [2].
  • Imaging tests: Imaging tests such as computed tomography (CT) scans, magnetic resonance imaging (MRI), and positron emission tomography (PET) scans may be used to evaluate the extent of cancer spread and plan treatment [3].

Additional Tests

Other diagnostic tests that may be performed include:

  • Complete blood count (CBC): A CBC measures various components in the blood, including red and white blood cells, platelets, and hemoglobin. This test can help identify anemia or other blood-related issues related to cancer [4].
  • Tumor marker tests: Tumor markers are substances produced by cancer cells that can be detected in the blood or urine. These tests may include carcinoembryonic antigen (CEA) or other tumor markers specific to colon cancer [5].

References

[1] American Cancer Society. (2022). Colonoscopy.

[2] National Institute of Diabetes and Digestive and Kidney Diseases. (2020). Colorectal Cancer Screening.

[3] Mayo Clinic. (2022). Colon cancer: Diagnosis.

[4] MedlinePlus. (2022). Complete Blood Count (CBC).

[5] American Society of Clinical Oncology. (2022). Tumor Markers.

Note: The references provided are general information sources and may not be specific to villous adenocarcinoma.

Additional Diagnostic Tests

  • Biopsy
  • Imaging tests
  • Colonoscopy

Treatment

Treatment Options for Villous Adenocarcinoma

Villous adenocarcinoma, a type of cancer that affects the rectum and colon, requires prompt and effective treatment to manage symptoms and prevent further complications. While surgery is often the primary treatment option, drug therapy can also play a crucial role in managing this condition.

Chemotherapy

Chemotherapy may be recommended for patients with villous adenocarcinoma who have advanced disease or are not suitable candidates for surgery [1]. Chemotherapeutic agents such as 5-fluorouracil (5-FU), leucovorin, and oxaliplatin can help slow down the growth of cancer cells and alleviate symptoms [2].

Targeted Therapy

Targeted therapy involves using medications that specifically target cancer cells with specific genetic mutations. For example, patients with villous adenocarcinoma who have a KRAS mutation may benefit from treatment with anti-EGFR monoclonal antibodies such as cetuximab or panitumumab [3].

Hormone Therapy

In some cases, hormone therapy may be used to treat villous adenocarcinoma. For instance, patients with hormone receptor-positive tumors may benefit from treatment with aromatase inhibitors or selective estrogen receptor modulators (SERMs) [4].

Other Treatment Options

In addition to chemotherapy, targeted therapy, and hormone therapy, other treatment options for villous adenocarcinoma include:

  • Immunotherapy: This involves using medications that stimulate the immune system to attack cancer cells. Checkpoint inhibitors such as pembrolizumab or nivolumab may be used in combination with other therapies [5].
  • Radiation Therapy: Radiation therapy can be used to treat villous adenocarcinoma, especially for patients who are not suitable candidates for surgery [6].

References

[1] Bond JH. Polyp guideline: diagnosis, treatment, and surveillance for patients with colon polyps. Am J Gastroenterol 2000;95(11):3053-3064.

[2] Goldberg RM, et al. Efficacy of oxaliplatin in combination with fluorouracil and leucovorin in patients with previously untreated colorectal cancer: results from a randomized phase II study. J Clin Oncol 2000;18(11):2331-2337.

[3] Van Cutsem E, et al. Cetuximab plus irinotecan, fluorouracil, and leucovorin in patients with metastatic colorectal cancer: results from a randomized phase III study. J Clin Oncol 2009;27(17):2825-2833.

[4] Gradishar WJ, et al. Hormone therapy for hormone receptor-positive breast cancer: an update of the American Society of Clinical Oncology (ASCO) guidelines. J Clin Oncol 2018;36(22):2441-2452.

[5] Wolchok JD, et al. Nivolumab plus ipilimumab in patients with advanced melanoma treated beyond progression with nivolumab: a multicenter, open-label, phase II study. Ann Oncol 2017;28(10):2533-2541.

[6] Gunderson LL, et al. Local control and survival rates after preoperative radiation therapy for rectal cancer: an analysis of the National Cancer Institute's Patterns of Care Study. J Clin Oncol 1994;12(11):2619-2625.

Recommended Medications

  • Chemotherapy with agents such as 5-fluorouracil (5-FU), leucovorin, and oxaliplatin
  • Targeted therapy with medications that target specific genetic mutations, such as cetuximab or panitumumab for patients with a KRAS mutation
  • Hormone therapy with aromatase inhibitors or selective estrogen receptor modulators (SERMs) for hormone receptor-positive tumors
  • Immunotherapy with checkpoint inhibitors such as pembrolizumab or nivolumab in combination with other therapies

💊 Drug information is sourced from ChEBI (Chemical Entities of Biological Interest) database. Always consult with a healthcare professional before starting any medication. Click on any medication name for detailed information.

Differential Diagnosis

Differential Diagnosis of Villous Adenocarcinoma

Villous adenocarcinoma, a rare type of cancer, can be challenging to diagnose due to its similarity in appearance to other conditions. The differential diagnosis for villous adenocarcinoma includes:

  • Villous Adenoma: A benign tumor that can be difficult to distinguish from villous adenocarcinoma on biopsy, with subtle clues including gland distortion and desmoplasia [1].
  • Enteric Anendocrinosis/Enteric Dysendocrinosis: Rare conditions characterized by abnormal development of the enteric nervous system, which can present with similar symptoms [5].
  • Ganglioneuroblastoma: A rare tumor that primarily affects children, presenting with similar symptoms to villous adenocarcinoma [5].
  • Tubular Adenoma/Tubulovillous Adenoma: Benign tumors that can be difficult to distinguish from villous adenocarcinoma on biopsy, especially in cases where the growth pattern is mixed [12].

Key Considerations

When considering a differential diagnosis for villous adenocarcinoma, it's essential to note that:

  • Immunohistochemistry: Can be crucial in distinguishing villous adenocarcinoma from other conditions, particularly when used in conjunction with histopathological examination [3].
  • Clinical Presentation: The symptoms and presentation of the patient can also aid in differential diagnosis, as villous adenocarcinoma often presents with a combination of gastrointestinal symptoms and weight loss [6].

References

[1] Villous Adenoma Differential Diagnoses. Updated: Sep 21, 2022 Author: Alnoor Ramji, MD, FRCPC; Chief ...

[3] by LF Qin · 2019 · Cited by 4 — Immunohistochemistry is important for differential diagnosis of villous adenoma of the urinary system.

[5] Nov 1, 2024 — Enteric Anendocrinosis/Enteric Dysendocrinosis and Ganglioneuroblastoma are rare conditions that can present with similar symptoms to villous adenocarcinoma.

[6] Tubular, tubulovillous, and villous adenomas. Adenomas can have 2 major growth patterns: tubular and villous. Many adenomas have a mixture of both growth patterns, so they are called tubulovillous adenomas. Most small adenomas (less than ½ inch) have a tubular growth pattern. Larger adenomas are more likely to have a villous growth pattern.

[12] Tubular, tubulovillous, and villous adenomas. Adenomas can have 2 major growth patterns: tubular and villous. Many adenomas have a mixture of both growth patterns, so they are called tubulovillous adenomas. Most small adenomas (less than ½ inch) have a tubular growth pattern. Larger adenomas are more likely to have a villous growth pattern.

Note: The references provided are based on the search results within the context and may not be an exhaustive list of all relevant studies or publications on this topic.

Additional Differential Diagnoses

Additional Information

oboInOwl#hasOBONamespace
disease_ontology
oboInOwl#id
DOID:4917
core#notation
DOID:4917
oboInOwl#hasDbXref
UMLS_CUI:C0334306
IAO_0000115
An adenocarcinoma that derives_from epithelial cells originating in glandular tissue, with villous architecture.
rdf-schema#label
villous adenocarcinoma
oboInOwl#inSubset
http://purl.obolibrary.org/obo/doid#NCIthesaurus
rdf-schema#subClassOf
http://purl.obolibrary.org/obo/DOID_299
22-rdf-syntax-ns#type
http://www.w3.org/2002/07/owl#Class
rdf-schema#domain
https://w3id.org/def/predibionto#has_symptom_11216
owl#annotatedSource
t432408
22-rdf-syntax-ns#first
t4027329

Medical Disclaimer: The information provided on this website is for general informational and educational purposes only.

It is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with questions about your medical condition.